These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32255405)

  • 21. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
    de Beer F; van Dijk KW; Jong MC; van Vark LC; van der Zee A; Hofker MH; Fallaux FJ; Hoeben RC; Smelt AH; Havekes LM
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1800-6. PubMed ID: 10894820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
    Utermann G; Vogelberg KH; Steinmetz A; Schoenborn W; Pruin N; Jaeschke M; Hees M; Canzler H
    Clin Genet; 1979 Jan; 15(1):37-62. PubMed ID: 215360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146-->Gln) are inefficiently converted to cholesterol-rich lipoproteins.
    Mulder M; van der Boom H; de Knijff P; Braam C; van den Maagdenberg A; Leuven JA; Havekes LM
    Atherosclerosis; 1994 Aug; 108(2):183-92. PubMed ID: 7980718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein B-48 and B-100 very low density lipoproteins. Comparison in dysbetalipoproteinemia (type III) and familial hypertriglyceridemia (type IV).
    Tercé F; Milne RW; Weech PK; Davignon J; Marcel YL
    Arteriosclerosis; 1985; 5(2):201-11. PubMed ID: 3977778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysbetalipoproteinemia and other lipid abnormalities related to apo E.
    Cenarro A; Bea AM; Gracia-Rubio I; Civeira F
    Clin Investig Arterioscler; 2021 May; 33 Suppl 2():50-55. PubMed ID: 34006354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of a very low density lipoprotein subpopulation from familial dysbetalipoproteinemia to in vitro lipolytic conversion to the low density lipoprotein density fraction.
    Chung BH; Segrest JP
    J Lipid Res; 1983 Sep; 24(9):1148-59. PubMed ID: 6631244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysbetalipoproteinemia: Differentiating Multifactorial Remnant Cholesterol Disease From Genetic ApoE Deficiency.
    Paquette M; Bernard S; Paré G; Baass A
    J Clin Endocrinol Metab; 2022 Jan; 107(2):538-548. PubMed ID: 34467996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype.
    Bea AM; Cenarro A; Marco-Bened V; Laclaustra M; Martn C; Ibarretxe D; Pint X; Arrobas T; Vials C; Civeira F; Olmos S
    Clin Chem; 2023 Feb; 69(2):140-148. PubMed ID: 36644927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
    Brunzell JD; Albers JJ; Chait A; Grundy SM; Groszek E; McDonald GB
    J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial dysbetalipoproteinemia: a potentially fatal disorder.
    Bari AU; Hashim R; Rahman SB; Hussain M
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):506-8. PubMed ID: 18798589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
    Smelt AH
    Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesteryl ester accumulation in mouse peritoneal macrophages induced by beta-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia.
    Bersot TP; Innerarity TL; Mahley RW; Havel RJ
    J Clin Invest; 1983 Sep; 72(3):1024-33. PubMed ID: 6309903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoproteins in familial dysbetalipoproteinemia. Variation of serum cholesterol level associated with VLDL concentration.
    Zhao SP; Smelt AH; Leuven JA; van den Maagdenberg AM; van der Laarse A; van 't Hooft FM
    Arterioscler Thromb; 1993 Feb; 13(2):316-23. PubMed ID: 8427867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Combined Dyslipidemia With a Complex Genetic Basis.
    Le R; Abbas M; McIntyre AD; Hegele RA
    J Investig Med High Impact Case Rep; 2019; 7():2324709619877050. PubMed ID: 31538826
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia.
    Rall SC; Weisgraber KH; Innerarity TL; Mahley RW
    J Clin Invest; 1983 Apr; 71(4):1023-31. PubMed ID: 6300187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-VLDL accumulation in familial dysbetalipoproteinemia is associated with increased exchange or diffusion of chylomicron lipids to apo B-100 containing triglyceride-rich lipoproteins.
    Demacker PN; Bredie SJ; Vogelaar JM; Hectors MP; van Heijst P; Stuyt PM; Stalenhoef AF
    Atherosclerosis; 1998 Jun; 138(2):301-12. PubMed ID: 9690913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin.
    Zhao SP; Smelt AH; Van den Maagdenberg AM; Van Tol A; Vroom TF; Gevers Leuven JA; Frants RR; Havekes LM; Van der Laarse A; Van 't Hooft FM
    Arterioscler Thromb; 1994 Nov; 14(11):1705-16. PubMed ID: 7947593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.